Enhanced inflammasome-mediated inflammation and impaired autophagy in peripheral blood mononuclear cells is associated with non-alcoholic fatty liver disease severity-Reference-Cited by-同舟云学术

Enhanced inflammasome-mediated inflammation and impaired autophagy in peripheral blood mononuclear cells is associated with non-alcoholic fatty liver disease severity

Published:2023-09 Issue: Volume:329 Page:121911
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Saha Samrat,Ray Sujay,Mandal Arpan,Das Ujjal,Bhattacharya Tuhin,Shireen Zofa,Sarkar Sankalita,Sharma Rakhi Dey,Ghosh Saurabh,Dey Sanjit

Funder

Department of Science and Technology, Ministry of Science and Technology, India

University Grants Commission

University of Calcutta

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference38 articles.

1. Non-alcoholic fatty liver disease and metabolic syndrome-position paper of the Indian National Association for the study of the liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of gastroenterology;Duseja;J Clin Exp Hepatol,2015

2. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease;Das;Hepatology,2010

3. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma;Burczynski;Clin. Cancer Res.,2005

4. Adaptive immunity: an emerging player in the progression of NAFLD;Sutti;Nat Rev Gastroenterol Hepatol,2020

5. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?;Tarantino;Eur. J. Gastroenterol. Hepatol.,2009

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mechanism and Therapeutic Prospect of Autophagy in Metabolic Dysfunction-Associated Steatotic Liver Diseas;Journal of Contemporary Medical Practice;2024-08-27

2. IRGM/Irgm1 increases autophagy to inhibit activation of NLRP3 inflammasome in inflammatory injury induced acute liver failure;Cell Death Discovery;2024-06-07

3. Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation;Journal of Hepatology;2024-06

4. Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads;Trends in Pharmacological Sciences;2024-01

5. IRGM/Irgm1 Increases Autophagy to Inhibit Activation of NLRP3 Inflammasome in Inflammatory Injury Induced Acute Liver Failure;2023-11-25